Hypogammaglobulinemia Diagnosis and Management

Introduction to Hypogammaglobulinemia

• The American College of Allergy, Asthma, and Immunology recommends considering secondary causes of hypogammaglobulinemia, such as hematologic malignancies and immunosuppressive medications, before evaluating for primary immunodeficiency disorders 2

Secondary Causes of Hypogammaglobulinemia

• Rituximab and other anti-CD20 therapies are associated with prolonged hypogammaglobulinemia, with 21% of patients on long-term rituximab developing IgG <5 g/L 1

Primary Immunodeficiency Considerations

• Common Variable Immunodeficiency (CVID) should be considered if secondary causes are excluded, and is associated with autoimmune complications and increased malignancy risk 2
• Selective IgA deficiency with IgG subclass deficiency can present with low total gamma globulin 2, 4

Diagnostic Evaluation

• A complete immunoglobulin panel, including IgG, IgA, IgM, and IgE levels, is recommended for initial laboratory evaluation 2
• Lymphocyte subset analysis, including CD3, CD4, CD8, CD19, and CD16/56, can assess T-cell and B-cell populations 2

Management of Hypogammaglobulinemia

• Immunoglobulin replacement therapy should be considered for patients with IgG <4 g/L and recurrent bacterial infections, or ≥2 severe recurrent infections by encapsulated bacteria regardless of IgG level 5
• The target trough IgG level with replacement therapy is 6-8 g/L 6

Monitoring and Follow-up

• Monthly IgG monitoring during replacement therapy is recommended, as well as regular assessment for infection frequency 5
• Reassessment at 6-month intervals can determine ongoing need for replacement therapy 6